Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radical of formulae (a) to (c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively, into cosmetic compositions.

 
Web www.patentalert.com

> Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides

~ 00321